The PR1 epitope is a nonameric peptide (VLQELNVTV) in complex with an HLA-A*02 molecule and is recognized by cytotoxic T lymphocytes when it is presented on the surface of CML or AML cells in patients. Here, HLA-A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.